Happy new year to you all. I hope you celebrated the start of 2014 in good spirits with family and friends. Now that we just passed a few days of the new year, it’s good to look ahead and think about what this year may bring us. But first, a quick look back. 2013 was quite a year for all of us at SUMMIT. We’ve been through many developments, in sometimes less than favourable circumstances. But we’ve also achieved a huge amount. Within automatic analyzer and reagents of clinical chemistry business we have made good progress: twenty new customers, getting upsales from our current clinical laboratories customers, successfully launching our new product line of chemistry ...view middle of the document...
As you might have known, starting the first of January of 2014, the Government of Republic of Indonesia launched a National Health Insurance1.
UU No 40 tahun 2004 tentang Sistem Jaminan Sosial Nasional (SJSN) dan UU No 24 tahun 2011 tentang Badan Penyelenggara Jaminan Sosial (BPJS)
All health care coverage under Askes (for civil servants), Jamsostek (for the private sector) and Asabri (for the police and army) will be transferred to BPJS Health Care (it is used to be PT. Askes) starting on January 1, 2014. By 2019, the system is intended to cover the entire population of 250-plus million people. This individual health insurance will cover promotive, preventive, curative and rehabilitative services. It includes medic and non medic benefits such as accommodation and ambulance. The impacts on in vitro diagnostics (IVD) business, our business field, will be as follows: Expanded market size on government sectors especially for basic laboratory testing (routine clinical chemistry, CBC, urine and microbiology) Downside on private sectors Potential price disparity between private sectors and government sectors (eprocurement and e-catalog) Next year, 2015, we will face the integration of ASEAN economic which is called the Asean Economic Community (AEC)2. AEC will transform ASEAN into a region with free movement of goods, services, investment, skilled labour, and freer flow of capital. In detail, ASEAN will become a single market and production base, a highly competitive economic region, a region of equitable economic development, and a region fully integrated into the global economy. The impact on IVD business in Indonesia will be as follows: Foreign investment on new hospital and laboratory Stimulate New Local and Overseas Manufacture Free movement of goods: this is quite unlikely as long as there is no significant price disparity between countries which this is role of
manufacturer/principals With these new situation changes and might be challenges, we do believe that there is also huge opportunities of expanding our mission to serve more patients...